IPF Partners

IPF Partners is a Luxembourg-based independent financing provider with a dedicated focus on the global healthcare sector. Operating across both Europe and North America, the firm distinguishes itself by offering bespoke financing solutions rather than traditional equity investments. Their approach encompasses a range of instruments, including senior and subordinated debt, royalty financing, and various hybrid structures, designed to meet the specific needs of healthcare businesses at different stages of their growth. This specialized focus allows them to deeply understand the unique challenges and opportunities within the life sciences, medical technology, and healthcare services sub-sectors.

The firm targets a broad spectrum of healthcare companies, ranging from innovative, venture-backed startups seeking initial growth capital to established large corporates requiring expansion or strategic financing. IPF Partners emphasizes a flexible and patient investment philosophy, largely due to its structure as a permanent capital vehicle rather than a traditional time-limited fund. This permanent capital base provides them with the unique ability to offer long-term financing solutions and adapt to the evolving needs of their portfolio companies without the pressure of a fund's typical exit horizon.

IPF Partners typically deploys significant capital into its investments. Their standard transaction sizes range from approximately €10 million to €100 million, which translates to roughly $10.8 million to $108 million based on recent exchange rates. This substantial check size positions them as a key player in providing growth and expansion capital to mid-to-large-sized healthcare enterprises, while also having the flexibility to support promising earlier-stage ventures that require substantial debt financing. For larger deals exceeding their typical range, they are open to co-investment opportunities, further extending their reach and capacity within the healthcare financing landscape.